As shown in Figure 3A, patient-derived NK cells showed a markedly decreased expression of CD16 and a trend of decreased expression of several other genes known to play a role in NK-mediated anti-tumor activity, including genes encoding for NKp46, CD69, CD62L, DAP10 and GZMB. The gene discussed is SELL; the disease is neoplasm.